ALMIRALL, S.A. «...1112131415...» Page 14 out of 48 from 01/07/1988 to 12/09/2024 The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish 03/10/2016 08:05 ALMIRALL, S.A. Others on business performance and financial information Almirall to Announce Late-Breaking Results for Investigational IL-23p19 inhibitor, Tildrakizumab, Achieves Primary End Point in Both Phase-3 Studies in Patients with Moderate-to-Severe Plaque Psoriasis Register number: 243306 03/10/2016 08:00 ALMIRALL, S.A. Others on business performance and financial information Almirall anuncia resultados para el inhibidor en investigación IL-23p19, Tildrakizumab, que alcanza los criterios de valoración primarios en ambos estudios fase 3 en pacientes con psoriasis en placa de moderada a severa Register number: 243305 28/09/2016 18:37 ALMIRALL, S.A. Others on business performance and financial information Almirall announces positive phase III results showing efficacy of LAS41008 (dimethyl fumarate), a new systemic oral drug for patients with chronic plaque psoriasis Register number: 243184 28/09/2016 18:30 ALMIRALL, S.A. Others on business performance and financial information Almirall presenta resultados positivos de fase III que demuestran la eficacia de LAS41008 (dimetil fumarato), un nuevo fármaco oral sistémico para pacientes con psoriasis en placa Register number: 243183 28/07/2016 07:50 ALMIRALL, S.A. Announcements of public presentations and meetings Encuentro con analistas e inversores institucionales: Presentación licencia para Tildrakizumab en Europa para Psoriasis Register number: 241381 27/07/2016 17:57 ALMIRALL, S.A. Strategic agreements with third parties Almirall and Sun Pharma enter into a License Agreement for Tildrakizumab in Europe for Psoriasis Register number: 241357 27/07/2016 17:51 ALMIRALL, S.A. Strategic agreements with third parties Almirall y Sun Pharma firman un acuerdo de licencia para Tildrakizumab en Europa para Psoriasis Register number: 241353 27/07/2016 12:23 ALMIRALL, S.A. Interim financial information La sociedad remite información sobre los resultados del primer semestre de 2016 Register number: 241321 26/07/2016 07:55 ALMIRALL, S.A. Information on P&L Almirall anuncia que hoy mantendrá una teleconferencia con analistas e inversores institucionales a las 10:00 am sobre los Resultados del primer semestre de 2016. Adjuntamos la presentación del evento y la nota de prensa remitida a los medios. Register number: 241195 22/07/2016 10:33 ALMIRALL, S.A. Strategic agreements with third parties Almirall announces a global licensing agreement with Patagonia for congenital ichthyosis Register number: 241083 Page 14 out of 48 «...1112131415...»